Narayanan M, Murthy P S, Munaf S A, Shah L C, Kini M D
I.V.F. and Infertility Unit, Almana General Hospital, Dammam, Kingdom of Saudi Arabia.
J Assist Reprod Genet. 1995 Oct;12(9):599-605. doi: 10.1007/BF02212582.
To compare the presence in levels of antiovarian antibodies (AOAb) in the pre- and postovulatory stage from serum of infertile patients undergoing intrauterine insemination (IUI) or in vitro fertilization (IVF) with outcome of the procedures.
Serum from 36 women undergoing IUI, 36 women undergoing IVF and 25 fertile, healthy controls were assayed for the presence of AOAb by a commercially available ELISA kit. AOAb was positive in 59.7% of infertile women, while none of the fertile controls were positive for AOAb. The levels of these antibodies increased as the patient age and the number of treatment attempts increased. Though the presence of AOAb did not affect oocyte recovery rate, it resulted in decreased fertilization rate, cleavage rate, and pregnancy rate in infertile women.
Our studies suggest that AOAb may be a cause of infertility and presence of these antibodies could have adverse effects on the outcome of assisted reproductive techniques.
比较接受宫内人工授精(IUI)或体外受精(IVF)的不孕患者排卵前和排卵后血清中抗卵巢抗体(AOAb)水平与手术结果之间的关系。
采用市售酶联免疫吸附测定(ELISA)试剂盒对36例行IUI的女性、36例行IVF的女性以及25名有生育能力的健康对照者的血清进行AOAb检测。59.7%的不孕女性AOAb呈阳性,而所有有生育能力的对照者AOAb均为阴性。这些抗体的水平随着患者年龄和治疗尝试次数的增加而升高。虽然AOAb的存在不影响卵母细胞回收率,但会导致不孕女性的受精率、卵裂率和妊娠率降低。
我们的研究表明,AOAb可能是不孕的一个原因,这些抗体的存在可能会对辅助生殖技术的结果产生不利影响。